Page last updated: 2024-09-03

astragaloside a and Peripheral Vascular Diseases

astragaloside a has been researched along with Peripheral Vascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, R; Hu, J; Lu, M; Mei, M; Tang, F; Wang, H; Xu, C; Yang, J; Zhou, M	1

Other Studies

1 other study(ies) available for astragaloside a and Peripheral Vascular Diseases

Article	Year
Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways. International immunopharmacology, 2016, Volume: 33 Topics: Animals; Anti-Inflammatory Agents; Aorta; Astragalus propinquus; Cardiomegaly; Cytokines; Humans; Isoproterenol; Male; NF-kappa B; Nitric Oxide Synthase Type III; Oxidative Coupling; Peripheral Vascular Diseases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Saponins; Signal Transduction; Triterpenes	2016

Article

Year

Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.

International immunopharmacology, 2016, Volume: 33

Topics: Animals; Anti-Inflammatory Agents; Aorta; Astragalus propinquus; Cardiomegaly; Cytokines; Humans; Isoproterenol; Male; NF-kappa B; Nitric Oxide Synthase Type III; Oxidative Coupling; Peripheral Vascular Diseases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Saponins; Signal Transduction; Triterpenes

2016